QuickView for TPKC1;jsessionid=6E914B61358162D1F9E976FF07D4FD40;jsessionid=AAD8726B21E0E9DB7D5D03D294075C93;jsessionid=DD3D21C6E9B9815DAB1D692C71EABDC2;jsessionid=300CC16A14A54871883F50ED7FBBD171 (gene)

1. TREK-1 inhibition promotes synaptic plasticity in the prelimbic cortex.
2. Tension activation of mechanosensitive two-pore domain K+ channels TRAAK, TREK-1, and TREK-2.
3. Novel potent blockers for TWIK-1/TREK-1 heterodimers as potential antidepressants.
4. Production of K2P2.1 (TREK-1) for structural studies.
5. Two-pore potassium channel TREK-1 (K2P2.1) regulates NLRP3 inflammasome activity in macrophages.

There were no clinical trials for TPKC1;jsessionid=6E914B61358162D1F9E976FF07D4FD40;jsessionid=AAD8726B21E0E9DB7D5D03D294075C93;jsessionid=DD3D21C6E9B9815DAB1D692C71EABDC2;jsessionid=300CC16A14A54871883F50ED7FBBD171